CTA
Chesley Taft & Associates Portfolio holdings
AUM
$2.24B
This Quarter Return
+5.41%
1 Year Return
+19.18%
3 Year Return
+75.84%
5 Year Return
+120.98%
10 Year Return
+286.6%
AUM
$1.67B
AUM Growth
+$1.67B
(+7%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
28.18%
Holding
298
New
12
Increased
114
Reduced
102
Closed
10
Top Buys
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$9.75M |
| 2 |
JPMorgan Chase
JPM
|
$7.41M |
| 3 |
Aptiv
APTV
|
$6.16M |
| 4 |
Amphenol
APH
|
$4.34M |
| 5 |
Sherwin-Williams
SHW
|
$2.74M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$11.4M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$2.35M |
| 3 |
Visa
V
|
$2.23M |
| 4 |
Microsoft
MSFT
|
$2.11M |
| 5 |
Invesco Financial Preferred ETF
PGF
|
$1.79M |
Sector Composition
| 1 | Technology | 19.85% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 11.21% |
| 4 | Communication Services | 9.22% |
| 5 | Consumer Discretionary | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
RTX Corp
RTX
$212B
| $4.91M | 0.29% | 63,025 +657 | +1% | +$51.2K |
|
77
Lowe's Companies
LOW
$145B
| $4.81M | 0.29% | 24,827 -293 | -1% | -$56.8K |
|
78
Vanguard Total Stock Market ETF
VTI
$526B
| $4.7M | 0.28% | 22,199 +818 | +4% | +$173K |
|
79
iShares Biotechnology ETF
IBB
$5.6B
| $4.7M | 0.28% | 30,871 -6,613 | -18% | -$1.01M |
|
80
Linde
LIN
$224B
| $4.55M | 0.27% | 15,957 -422 | -3% | -$120K |
|
81
Blackrock
BLK
$175B
| $4.53M | 0.27% | 5,777 -23 | -0.4% | -$18K |
|
82
Chevron
CVX
$324B
| $4.51M | 0.27% | 43,135 +4,379 | +11% | +$458K |
|
83
Vanguard Mid-Cap ETF
VO
$87.5B
| $4.47M | 0.27% | 19,758 +3,255 | +20% | +$736K |
|
84
Wells Fargo
WFC
$263B
| $4.44M | 0.27% | 112,445 +6,715 | +6% | +$265K |
|
85
Merck
MRK
$210B
| $4.43M | 0.26% | 57,565 +450 | +0.8% | +$34.7K |
|
86
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.44B
| $4.25M | 0.25% | 85,719 +1,950 | +2% | +$96.6K |
|
|
87
Sherwin-Williams
SHW
$91.2B
| $4.13M | 0.25% | 16,123 +10,717 | +198% | +$2.74M |
|
88
Eli Lilly
LLY
$657B
| $4.09M | 0.24% | 22,145 +250 | +1% | +$46.2K |
|
89
Edwards Lifesciences
EW
$47.8B
| $3.91M | 0.23% | 45,569 -890 | -2% | -$76.3K |
|
90
Fifth Third Bancorp
FITB
$30.3B
| $3.85M | 0.23% | 100,750 +2,675 | +3% | +$102K |
|
91
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.2B
| $3.74M | 0.22% | 63,313 -16,495 | -21% | -$975K |
|
92
Crown Castle
CCI
$43.2B
| $3.74M | 0.22% | 21,065 -135 | -0.6% | -$24K |
|
93
Texas Instruments
TXN
$184B
| $3.61M | 0.22% | 18,350 +150 | +0.8% | +$29.5K |
|
94
Zoetis
ZTS
$69.3B
| $3.55M | 0.21% | 22,402 -2,613 | -10% | -$414K |
|
95
Automatic Data Processing
ADP
$123B
| $3.52M | 0.21% | 18,249 | – | – |
|
96
TJX Companies
TJX
$152B
| $3.51M | 0.21% | 51,735 +1,605 | +3% | +$109K |
|
97
Caesars Entertainment
CZR
$5.57B
| $3.41M | 0.2% | 37,802 | – | – |
|
98
Target
TGT
$43.6B
| $3.34M | 0.2% | 16,254 -35 | -0.2% | -$7.19K |
|
99
Alcon
ALC
$39.5B
| $3.34M | 0.2% | 46,264 +2,028 | +5% | +$146K |
|
100
Novartis
NVS
$245B
| $3.34M | 0.2% | 38,212 -17,308 | -31% | -$1.51M |
|